Combination drugs like Qsymia (phentermine-topiramate) and Contrave (naltrexone-bupropion) are also noted for their effectiveness
Globally, diabetes and obesity remain critical health challenges, affecting more than 800 million and 1 billion people, respectively, according to WHO estimates
But repeated sessions especially at high doses can increase cumulative risk
Provides gradual dose escalation and automated side-effect monitoring for safer treatment continuity
Instead, they may elevate the risk of pancreatitis, which can be managed by ensuring gradual weight loss and appropriate dosing of the medication
Clean technical presentation This product is supplied in lyophilised form, supporting stable storage and practical handling within a research setting